Can Rocket Lab Neutron turn SpaceX IPO excitement into a lasting breakout for RKLB investors?
Why Is Rocket Lab USA, Inc. Gaining Amid SpaceX Hype?
Rocket Lab USA, Inc. gained 5.8% to $121.38 after the bell—outpacing the NASDAQ’s +0.4% intraday move—as space equities caught a powerful tailwind from SpaceX’s $1.78 trillion IPO valuation pitch, led by Goldman Sachs. Virgin Galactic (SPCE) jumped 14% to $4.87, while Rocket Lab USA, Inc. climbed alongside it, reflecting a classic ‘halo trade’ in which investor attention on a dominant private player lifts liquid public proxies. Unlike many space names, Rocket Lab USA, Inc. combines speculative upside with tangible progress: a $2.2 billion backlog, record quarterly revenue, and a clear path to operational scale via the Rocket Lab Neutron program. Analysts at RBC Capital Markets recently reiterated their ‘Outperform’ rating, citing Neutron’s potential to capture 18–22% of the medium-lift market by 2028.
How Does Rocket Lab Neutron Change the Competitive Math?
The Rocket Lab Neutron isn’t just another rocket—it’s a strategic pivot into high-frequency, reusable medium-lift capability designed for constellation deployment, national security payloads, and lunar logistics. While NVIDIA powers AI infrastructure and Tesla scales battery ecosystems, Rocket Lab USA, Inc. is building the orbital transport layer that enables next-generation space-based computing and sensing. Its Neutron vehicle targets 8–12 launches per year by 2027, directly competing with United Launch Alliance’s Vulcan and Firefly Aerospace’s Blue Ghost—yet with a faster cadence and lower marginal cost per flight. Citigroup analysts note Neutron’s 15-ton LEO capacity and rapid reusability could make it the preferred platform for U.S. Space Force’s ‘Tranche 3’ procurement, a $4.2 billion opportunity currently under RFP review.
What’s Driving the Backlog—and Is It Real?
Rocket Lab USA, Inc. reported $200 million in Q1 2026 revenue—64% higher year over year—and a $2.2 billion total backlog, including $1.1 billion in firm government contracts. That figure includes multi-year agreements with the U.S. Air Force, NASA’s CLPS program, and commercial satellite operators. Importantly, over 65% of the backlog is tied to Neutron-specific missions or Neutron-integrated payloads—signaling strong early adoption ahead of first flight. Morgan Stanley analysts upgraded Rocket Lab USA, Inc. to ‘Overweight’ in May, citing ‘unusually de-risked execution’ on Neutron’s heat shield testing and stage separation simulations, both completed successfully in April 2026.
What Comes After the SpaceX IPO Pop?
SpaceX’s potential June 12 debut under ticker SPCX could trigger profit-taking in volatile names like Rocket Lab USA, Inc. and Virgin Galactic—especially if pricing lands below $1.6 trillion. But the longer-term catalyst remains the Rocket Lab Neutron launch, now scheduled for Q4 2026 from Launch Complex 3 in Wallops Island. That event will be the first true stress test of Rocket Lab USA, Inc.’s vertical integration, and Wall Street will watch margins closely: Neutron’s production line is expected to reduce per-launch cost by 37% versus Electron. Meanwhile, the FY2027 defense budget—due before Congress in mid-July—will determine whether space procurement remains a multi-year tailwind or a one-cycle bump. The Space Development Agency’s budget line item is expected to grow 22% year over year, per Bloomberg analysis.
How Do Space Stocks Fit in a Broader Portfolio?
Neutron isn’t a concept—it’s a booked, funded, and tested system. That changes the risk calculus.— RBC Capital Markets analyst team
Rocket Lab USA, Inc. remains a high-beta, growth-at-a-premium holding—but one increasingly anchored by fundamentals. Its 74% year-to-date gain outpaces the S&P 500’s +11% and the NASDAQ’s +19%, yet its P/S ratio of 14.2 sits below Apple’s 32.5 and Tesla’s 68. That valuation gap reflects skepticism about near-term profitability, not demand. For U.S. investors seeking asymmetric exposure to U.S. space dominance, Rocket Lab USA, Inc. offers a rare blend: public liquidity, government-backed contracts, and a proprietary launch vehicle in final pre-flight readiness. As RBC Capital Markets emphasized: ‘Neutron isn’t a concept—it’s a booked, funded, and tested system. That changes the risk calculus.’
